PTC Therapeutics | PTCT - 流动资产



金融业
股票价格
USD 60.59
资产
USD 3.25B
现金及等价物
USD 1.05B
销售成本
USD 19.92M
流动资产
USD 2.62B
流动负债
USD 771.07M
债务
USD 696.47M
EBIT
USD 146.03M
EBITDA
USD 161.9M
员工
939
EPS每股收益
USD 0.92
股本和储备
USD -165.36M
销售毛利
USD 340.6M
债务利息支出
USD 3.25B
贷款资金
USD 535.52M
市值
USD 4.65B
净收入
USD 83.5M
营业费用
USD 211.54M
营业利润
USD 148.98M
普通股股本
USD 83.33M
PE价格收益
8.76
税前利润
USD 97.55M
销售收入
USD 361M
销售和管理费用
USD 80.63M
股票
USD 91.35M
贸易债权人
USD 40.45M
应收帐款人
USD 239.04M


流动资产 更改 日
Acadia Pharmaceuticals USD 1.22B 128.53M 2026-06
Alnylam Pharmaceuticals USD 4.62B 400.86M 2026-06
Amgen USD 34.96B 3.49B 2026-06
BioCryst Pharmaceuticals USD 484.68M 111.06M 2026-06
Biogen USD 7.31B 1.88B 2026-06
BioMarin Pharmaceutical USD 3.97B 633.45M 2026-06
Cytokinetics USD 1.21B 369.02M 2026-06
Daiichi Sankyo JPY 2.23T 91.92B 2026-06
Enanta Pharmaceuticals USD 198.68M 5.65M 2025-12
Gilead Sciences USD 12.53B 6.11B 2026-06
Incyte USD 6.03B 542.31M 2026-06
Ionis Pharmaceuticals USD 2.49B 446.73M 2026-06
Ironwood Pharmaceuticals USD 332.29M 58.11M 2026-03
Karyopharm Therapeutics USD 126.33M 23.19M 2026-03
Novartis USD 27.35B 744M 2026-06
Pfizer USD 41.36B 1.46B 2026-06
PTC Therapeutics USD 2.62B 363.36M 2026-06
Puma Biotechnology USD 143.58M 7M 2025-09
Roche Holding CHF 35.44B 3.29B 2026-06
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Sarepta Therapeutics USD 2.22B 86.05M 2026-06
TG Therapeutics USD 1.15B 58.72M 2026-06
Ultragenyx Pharmaceutical USD 606M 51M 2026-06
Vertex Pharmaceuticals USD 12.54B 813.4M 2026-06
Xencor USD 523.21M 40.36M 2026-06